Fig. 1

Antibody responses following mild/moderate SARS-CoV-2 infection. A Presence of anti-Spike IgG in convalescence serum (n = 52). B Pseudovirus neutralisation activity in anti-Spike IgG seropositive sera following mild/moderate COVID-19 (n = 45). Data was log 10 transformed and statistics were calculated using ordinary one-way ANOVA and p value adjusted for multiple comparison using Šídák’s multiple comparisons test. Vertical bars represent geometric mean and horizontal bars represent 95% confidence intervals. A p < 0.05 was regarded as statistically significant